Century Therapeutics Inc — Cash Flow (NASDAQ:IPSC) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 89 M14.05 M88.35 M110.14 M 112.02 M Cash from investing activities 298.34 M13.13 M61.13 M47.48 M 115.75 M Cash from financing activities 417.77 M27.16 M9.72 M74.56 M -482 K Free cash flow 44.03 M-16.55 M74.61 M109.98 M 111.03 M

ニュース

TD Cowen、Century Therapeutics株を買い推奨で新規カバレッジ開始

TD Cowen initiates Century Therapeutics stock rating at Buy

クリア・ストリート、センチュリー・セラピューティクスの株式に買い推奨を維持、目標価格$6.60

Oracle, Palantir among market cap stock movers on Monday

Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know

Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler

クリア・ストリート、センチュリー・セラピューティクスの目標株価を6.60ドルに引き下げ

Century Therapeutics stock price target lowered to $6.60 at Clear Street

Century Therapeutics secures $135 million in private placement

FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug

Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain

Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors